Table 136Relative risk of skin cancer in people treated with etanercept compared with the general population

StudyStandardised incidence ratio*
SCCBCC
Reference group: South-eastern Arizona Skin Cancer Registry
PAPP2012A1.08 (0.29–2.76)0.52 (0.23–1.03)
Reference group: Rochester Epidemiology Project; Minnesota
PAPP2012A2.68 (0.72–6.87)-
Reference group: Dutch General Practice Registry
VANLUMIG201281.4 (39.0–149.8)12.2 (5.9–22.5)
*

Standardised incidence ratio = numbers observed/numbers expected

From: 9, Phototherapy

Cover of Psoriasis
Psoriasis: Assessment and Management of Psoriasis.
NICE Clinical Guidelines, No. 153.
National Clinical Guideline Centre (UK).
Copyright © National Clinical Guideline Centre - October 2012.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.